Tenaya therapeutics to participate at chardan's 7th annual genetic medicines and cell therapy manufacturing summit

South san francisco, calif., april 21, 2023 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that faraz ali, chief executive officer, will participate at chardan's 7th annual genetic medicines and cell therapy manufacturing summit. details of participation are as follows:
TNYA Ratings Summary
TNYA Quant Ranking